Found 7 matching trials
Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults
PHASE2This was a Phase II, randomized, double-blind, placebo-controlled trial con...
A Study to Evaluate Safety and Immunogenicity of AERAS-402
PHASE1This Phase I study will be conducted as a randomized, double-blind, placebo...
A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402
PHASE1Healthy adults received BCG on Study Day -84, followed by randomization on ...
Location
Multiple Locations
A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB
PHASE1The available live tuberculosis vaccine Bacillus Calmette-Guérin (BCG) prov...
Location
Kenya Medical Research Institute
Study of AERAS-402 in Healthy Infants
PHASE1AERAS-402 will be given to infants of at least 16 weeks of age who have alr...
Location
Boro Heath Center
Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A
PHASE1This trial will investigate the administration of two new tuberculosis vacc...
Location
Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Churchill Hospital
A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB
PHASE2This was a double-blind, randomized, placebo-controlled dose-escalation stu...
Location
University of Cape Town Lung Institute Pty (Ltd)